Pacific Edge Ltd

PEB

Company Profile

  • Business description

    Pacific Edge Ltd is a New Zealand-based company involved in researching, developing, and commercialising new diagnostic and prognostic tools for the early detection and management of cancers. It manages and operates the laboratories used for the detection of bladder cancer. It operates in two segments: Commercial, which includes sales, marketing, laboratory, and support operations to run the commercial businesses internationally; and Research, which is into research and development of diagnostic and prognostic products for human cancer. The commercial segment contributes to the majority of the revenue. Pacific Edge has a product in the marketplace called Cxbladder. Its geographical segments are the United States, which generates maximum revenue, New Zealand, and the Rest of the World.

  • Contact

    87 Saint David Street
    P.O. Box 56
    DunedinSTL9016
    NZL

    T: +64 35776733

    https://www.pacificedgedx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 March 2027

    Employees

    34

Stocks News & Analysis

stocks

ASX energy giant undervalued despite commissioning challenges

Near-term hurdles, long-term upside.
stocks

Undervalued ASX share upgrades guidance

Market share gains drive earnings upgrade despite a weak US housing backdrop.
stocks

ASX major bank drives strong quarterly profit

Profit momentum remains robust yet shares overvalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,112.0079.700.88%
CAC 408,452.4046.340.55%
DAX 4025,519.71158.680.63%
Dow JONES (US)52,210.08262.830.51%
FTSE 10010,791.069.310.09%
HKSE25,278.7071.520.28%
NASDAQ24,932.0843.74-0.18%
Nikkei 22562,364.922,566.27-3.95%
NZX 50 Index13,861.9311.240.08%
S&P 5007,413.181.200.02%
S&P/ASX 2008,947.8085.600.97%
SSE Composite Index3,813.3144.93-1.16%

Market Movers